Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma
BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...
Samsung Biologics bags $514 mn CMO contract from US pharma
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...
Samsung Biologics signs $1.4 bn CMO deal with European pharma
South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...
Samsung’s biotech duo on a roll with $1.1 bn CMO order
Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract man...
Samsung Life Science invests in US biotech firm Latus Bio
Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the ...
Samsung invests in BrickBio in US
Samsung Group announced on Tuesday that its Life Science Fund has invested in the US-based antibody-drug conjugates (ADC) and gene therapy technol...
Samsung targets gene therapy sector through US investments
Samsung Group is targeting the gene therapy business through investments in US biotechnology companies as the leading South Korean conglomerate is s...
ToolGen gets FDA approval for TGT-001 as ODD
South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
Samsung Biologics reaches record-breaking annual orders
Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...
Dong-A ST, UMass to jointly research for gene therapy
South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...
SK becomes top shareholder of US contract drug maker CBM
SK Pharmteco Co., a South Korean contract development and manufacturing organization (CDMO), said on Wednesday it has secured management rights of t...
KCGI Asset Management appoints former KIS head as new CMO
South Korea’s KCGI Asset Management, formerly Meritz Asset Management, announced on Friday that it has hired Cho Won-bok, former division head...
SK Bioscience buys 6.5 million Novavax shares for $83.4 million
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...
S.Korea's ToolGen develops gene-edited cow for artificial blood
South Korean genome editing developer ToolGen Inc. has teamed up with Lartbio Technology, a Seoul-based transgenic animal development company, to de...
Hyundai E&C to develop future residential model All Life-care House
South Korea's Hyundai Engineering & Construction (Hyundai E&C) has announced plans to create a future residential model, the All Life-care H...
LabGenomics, Amorepacific sign gene testing service supply deal
South Korea's molecular diagnostics company LabGenomics Co. announced on Monday that it has signed a gene testing service supply contract with Amore...
S.Korea's iNtRON launches halal test kit to target Middle Eastern market
South Korean biotech firm iNtRON Biotechnology Inc. is focusing on the Middle Eastern market with the introduction of its "LiliF Halal Real-time PCR...
Korea's ST Pharm completes new R&D hub for gene therapy
ST Pharm Co., a South Korean drug raw material-producing subsidiary of Dong-A Socio Holdings, said on Friday that it has finished building an R&...
Samsung Biologics bags $183 million CMO order from Pfizer
Samsung Biologics Co., the world’s No. 1 contract drug maker in terms of production capacity, has won a $182.7 million contract manufacturing ...
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments
Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...
ToolGen, ANLBIO to jointly develop progeria treatments
South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...
Seegene's COVID-19 diagnostic product wins Product of the Year Award
Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...
Samsung Biologics in CDO deal talks with global pharma firm
FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...
Korea's Samsung Biologics signs $296 mn CMO deal with GSK
South Korea’s Samsung Biologics Co. has signed a $296.1 million deal to supply biopharmaceutical products to UK-based multinational pharma gia...
K-bio firms embrace gene therapy CDMO as Samsung looks the other way
South Korea’s major biopharmaceutical companies are rapidly embracing the cell and gene therapy business under a contract drug-making mechanis...
Samsung Biologics signs $81 mn CMO deal with Novartis
South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...
Kolon Life inks technology transfer deal with Juniper Biologics
South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Samsung’s Life Science Fund invests in US biotech Jaguar Gene Therapy
Samsung Group’s 150 billion won ($124 million) Life Science Fund launched last year has chosen a leading US gene therapy development company a...
